Mutant mice treated with the NLRP3-inhibitor MCC950, show normal EF and fractional shortening, develop no arrhythmias and show no cardiac fibrosis unlike vehicle-treated littermates [59]. This evidence concerns the gene NLRP3 and Arrhythmia.